{"id":96455,"date":"2019-09-20T01:02:24","date_gmt":"2019-09-20T08:02:24","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2019\/09\/agex-therapeutics-publishes-theoretical-basis-of-human-cell-age-reversal-in-the-journal-regenerative-medicine"},"modified":"2019-09-20T01:02:24","modified_gmt":"2019-09-20T08:02:24","slug":"agex-therapeutics-publishes-theoretical-basis-of-human-cell-age-reversal-in-the-journal-regenerative-medicine","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2019\/09\/agex-therapeutics-publishes-theoretical-basis-of-human-cell-age-reversal-in-the-journal-regenerative-medicine","title":{"rendered":"AgeX Therapeutics Publishes Theoretical Basis of Human Cell Age-Reversal in the Journal Regenerative Medicine"},"content":{"rendered":"

<\/a><\/p>\n

A unified theory of ageing, there is a vid and a paper linked within.<\/p>\n

\n

ALAMEDA, Calif.\u2014( BUSINESS WIRE<\/a> )\u2014AgeX Therapeutics<\/a>, Inc. (\u201cAgeX\u201d; NYSE American: AGE), a biotechnology company focused on therapeutics for human aging and regeneration, announced today that founder and CEO Michael D. West, Ph.D., and colleagues have authored a paper<\/a> in the peer-reviewed scientific journal Regenerative Medicine<\/i><\/a> on the theoretical foundation of the Company\u2019s induced Tissue Regeneration (iTRTM<\/sup>) technology. The paper presents the work of the company\u2019s scientists in describing a unified theory of aging and regeneration that could pave the way for the development of new therapies for a variety of age-related degenerative diseases and conditions.<\/p>\n

<\/blockquote>\n

\u201cThe longevity sector is advancing at an accelerating pace, but for the most part, without a consensus on the fundamental root causes of aging,\u201d commented Dr. West. \u201cWe believe that it is now possible to collate the diverse observations about aging into a unified model. In the paper titled, \u2018Toward a Unified Theory of Aging and Regeneration\u2019 we outline such a theory that underlies the technological underpinnings of the company\u2019s induced tissue regeneration (iTR<\/a>) program.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"

A unified theory of ageing, there is a vid and a paper linked within. ALAMEDA, Calif.\u2014( BUSINESS WIRE )\u2014AgeX Therapeutics, Inc. (\u201cAgeX\u201d; NYSE American: AGE), a biotechnology company focused on therapeutics for human aging and regeneration, announced today that founder and CEO Michael D. West, Ph.D., and colleagues have authored a paper in the peer-reviewed [\u2026]<\/p>\n","protected":false},"author":388,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,43,269],"tags":[],"class_list":["post-96455","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-business","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/96455","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/388"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=96455"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/96455\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=96455"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=96455"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=96455"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}